Scientific publications
-
Dapiglutide, a Once Weekly GLP 1R/GLP 2R Dual Agonist, Was Safe and Well Tolerated and Showed Dose Dependent Body Weight Loss Over 4 Weeks in Healthy Subjects
-
Antidiabetic Potential of a Novel, Long Acting Amylin Analogue ZP8396 in ZDF Rats
-
ZP8396, a Novel Amylin Analogue Induces Weight Loss in DIO Rats With a Formulation Space at Physiological pH
-
Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
-
Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study
-
Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
